Visceral fat, strength, and metabolic precision now matter more than weight alone — redefining cardiovascular prevention.

Read post

Five key metrics—blood pressure, ApoB, glucose patterns, waist ratio, and muscle strength—redefine cardiovascular risk beyond outdated BMI measurements.

Read Post

GLP-1 therapies reduce cardiovascular events, likely through visceral adipose tissue reduction, reframing cardiology treatment toward upstream metabolic disease targeting

Read post

Visceral fat sits silently behind heart disease, dementia, prediabetes, joint pain and aggressive prostate cancer risk

Read post

Fructose quietly drives visceral fat, insulin resistance, and small dense LDL, reshaping cardiovascular risk within today’s ultra-processed food environment modern.

Read post

Two patients. Same LDL. One needs a statin. The other needs a tape measure. Here's how to tell which one you are.

Read post

Simple grip strength testing predicts heart disease better than blood pressure. Two three-minute muscle function tests reveal your metabolic resilience and can be tracked at home monthly. Strong muscles actively fight visceral fat accumulation across all cardiovascular risk factors.

Read post

In cardiometabolic medicine, muscle is not a cosmetic tissue but a metabolic organ. Evidence consistently shows that strength, not muscle mass, predicts insulin resistance, cardiovascular risk, and survival. Many older adults are not losing muscle tissue — they are losing muscle function, and that is the pathology that matters.

Read Blog